1. Home
  2. RLI vs SRRK Comparison

RLI vs SRRK Comparison

Compare RLI & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RLI Corp. (DE)

RLI

RLI Corp. (DE)

HOLD

Current Price

$62.33

Market Cap

5.4B

Sector

Finance

ML Signal

HOLD

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$47.78

Market Cap

4.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLI
SRRK
Founded
1965
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.4B
4.9B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
RLI
SRRK
Price
$62.33
$47.78
Analyst Decision
Hold
Strong Buy
Analyst Count
7
11
Target Price
$66.00
$51.20
AVG Volume (30 Days)
684.5K
852.2K
Earning Date
01-01-0001
05-28-2026
Dividend Yield
4.21%
N/A
EPS Growth
16.84
N/A
EPS
4.37
N/A
Revenue
$1,882,448,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.17
$449.79
P/E Ratio
$14.50
N/A
Revenue Growth
6.33
N/A
52 Week Low
$55.80
$22.71
52 Week High
$81.79
$49.82

Technical Indicators

Market Signals
Indicator
RLI
SRRK
Relative Strength Index (RSI) 55.16 56.36
Support Level $62.04 $45.59
Resistance Level $63.61 $48.31
Average True Range (ATR) 1.43 2.18
MACD 0.20 -0.26
Stochastic Oscillator 63.05 82.09

Price Performance

Historical Comparison
RLI
SRRK

About RLI RLI Corp. (DE)

RLI Corp underwrites property and casualty insurance through its subsidiaries. The company offers insurance coverage in the specialty admitted market, where the products are designed for special risks. It also offers products in the excess and surplus markets, which provides an alternative for customers with risks or loss exposures that generally cannot be written in the standard admitted market. RLI distributes property and casualty insurance through its wholly-owned branch offices that market to wholesale and retail producers. The company's insurance operation segments include Casualty, Property, and Surety and it derives a majority of its revenue from the Casualty segment.

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

Share on Social Networks: